Skip to content
Aperlena
Free alerts
Log in

España - Antimicobacterianos - 2o Contrato basado en el AM 111/2022 para el suministro de enzimas, medicamentos huérfanos y para el tratamiento de enfermedades raras

Awarded Contract award

Key facts

Awarded
Winner
SANOFI AVENTIS, S.A.; TAKEDA FARMACÉUTICA ESPAÑA S.A.; EUROCEPT INTERNATIONAL B.V; IMMEDICA PHARMA IBERIA, S.L.; PFIZER, S.L.U.; AUROVITAS SPAIN, S.A.U.; OTSUKA PHARMACEUTICAL, S.A.; BIOGEN SPAIN, S.L.; ALNYLAM PHARMACEUTICALS SPAIN SL; ACCORD HEALTHCARE S.L.U.
Awarded value
€58,239,932
Estimated value
€100,883,809
Buyer
Dirección General de Gestión Económica, Contratación e Infraestructuras de la Conselleria de Sanidad
Where
Spain Comunitat Valenciana
Procedure
Negotiated procedure The buyer selects candidates, then negotiates the offers before choosing. Full entry Above the EU threshold A contract large enough that EU-wide rules apply and it must be published on TED. Full entry
CPV code The EU's common vocabulary for what is being bought: an eight-digit code every notice carries. Full entry
33651300 Antimycobacterials 33610000 Medicinal products for the alimentary tract and metabolism 33616000 Vitamins
5 more codes
33632000 Medicinal products for the musculo-skeletal system 33651200 Antimycotics for systemic use 33652000 Antineoplastic and immunomodulating agents 33652300 Immunosuppressive agents 33661700 Other nervous system medicinal products
Original language
Spanish
Source
via TED - Tenders Electronic Daily (Publications Office of the EU), verified 1 month ago
Notice number
362720-2026
Watch this tender

Bidding is closed. An award or a correction on this notice: an email when the register sees it. Log in

  1. Awarded
  2. Published

Description

Suministro de forma centralizada de medicamentos de uso humano enzimas, medicamentos huérfanos y para el tratamiento de enfermedades raras en el ámbito de la sanidad pública valenciana. Idursulfasa 2 mg/ml vial; Velaglucerasa alfa 400 U vial (huérfano); Fenilbutirato de sodio; Teduglutida 5 mg vial (huérfano); Fenilbutirato de glicerol 1,1 g/ml solución /suspensión oral (huérfano); Eliglustat 84 mg capsulas (huérfano); Tafamidis 20 mg capsulas (huérfano); Nitisinona 20mg capsulas; Delamanid 50 mg comprimidos (huérfano); Isavuconazol 200 mg inyectable (huérfano) - Isavuconazol 100 mg capsulas (huérfano); Plerixafor 20mg/ml inyectable; Nusinersen 12mg vial (huérfano); Givosiran solución inyectable 189 mg / 1 ml de 1 ml (huérfano); Nitisinona 2-5-10 mg cápsulas; Miglustat 100 mg cápsulas; Ácido carglúmico 200 mg comprimidos dispersables; Imiglucerasa 400 U inyectable; Agalsidasa alfa 1 mg/ml vial; Agalsidasa beta 5-35 mg vial; Laronidasa 100 U/ml vial; Alglucosidasa alfa 50 mg vial

Official source

Source: TED - Tenders Electronic Daily (Publications Office of the EU)

Always verify details on the official notice.

Last verified against TED - Tenders Electronic Daily (Publications Office of the EU) 1 month ago

View the official notice

More from this buyer

Full buyer profile

6 open tenders right now

Recent awards

Similar tenders

Market context

Avg. open tender · Medical equipment & pharmaceuticals
€10,020,608
9,792 open across Europe right now
Buyer track record on Aperlena
179 notices tracked · 105 awarded
€385,432,844 in awarded contracts

Never miss a tender like this

756 new notices in Medical equipment & pharmaceuticals in Spain in the last 7 days. Get an email when new ones appear. Free.

Set up my alert
Open notice

Keyboard shortcuts

Read a list without reaching for the mouse. The shortcuts stay quiet while you type in a field.

j
Next result
k
Previous result
Enter
Open the result
n
Next page
p
Previous page
c
Compare this result
s
Shortlist this result
/
Search from any page
Ctrl K
Search from any page
?
Show these shortcuts
Esc
Close

Start from a question

Browse by sector